BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee BP, Vittinghoff E, Dodge JL, Cullaro G, Terrault NA. National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States. JAMA Intern Med. 2019;179:340-348. [PMID: 30667468 DOI: 10.1001/jamainternmed.2018.6536] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 30.5] [Reference Citation Analysis]
Number Citing Articles
1 Noureddin N, Yang JD, Alkhouri N, Noreen SM, Toll AE, Todo T, Ayoub W, Kuo A, Voidonikolas G, Kotler HG, Pelphrey MD, Durand BJ, Kosari K, Brennan TV, Kim I, Klein AS, Seki E, Nissen NN, Lu SC, Sundaram V, Noureddin M. Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004-2018 Analysis. Transplant Direct 2020;6:e612. [PMID: 33134488 DOI: 10.1097/TXD.0000000000001051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Doycheva I, Zhang T, Amjad W, Thuluvath PJ. Diabetes and Hepatocellular Carcinoma: Incidence Trends and Impact of Liver Disease Etiology. J Clin Exp Hepatol 2020;10:296-303. [PMID: 32655232 DOI: 10.1016/j.jceh.2019.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
3 Pimienta M, Dodge J, Terrault NA. The Internet as a Tool for Liver Transplant Programs to Combat Stigma Related to Alcohol Use Disorder. Hepatol Commun 2021;5:155-7. [PMID: 33553965 DOI: 10.1002/hep4.1649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Choudhary NS, Saraf N, Mehrotra S, Saigal S, Soin AS. Recidivism in Liver Transplant Recipients for Alcohol-related Liver Disease. J Clin Exp Hepatol 2021;11:387-96. [PMID: 33994719 DOI: 10.1016/j.jceh.2020.08.011] [Reference Citation Analysis]
5 Mellinger JL. Living Donor Liver Transplant in Alcohol-related Liver Disease: An Option Whose Time Has Come. Transplantation 2020;104:235-6. [PMID: 31107824 DOI: 10.1097/TP.0000000000002784] [Reference Citation Analysis]
6 Herrick-Reynolds KM, Punchhi G, Greenberg RS, Strauss AT, Boyarsky BJ, Weeks-Groh SR, Krach MR, Anders RA, Gurakar A, Chen PH, Segev DL, King EA, Philosophe B, Ottman SE, Wesson RN, Garonzik-Wang JM, Cameron AM. Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease. JAMA Surg 2021. [PMID: 34379106 DOI: 10.1001/jamasurg.2021.3748] [Reference Citation Analysis]
7 Hartmann P, Schnabl B. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease. Semin Liver Dis 2021;41:87-102. [PMID: 33957682 DOI: 10.1055/s-0040-1719174] [Reference Citation Analysis]
8 Avanceña ALV, Miller N, Uttal SE, Hutton DW, Mellinger JL. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis. J Hepatol 2021;74:1286-94. [PMID: 33326815 DOI: 10.1016/j.jhep.2020.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
9 Lang S, Schnabl B. Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. Cell Host Microbe 2020;28:233-44. [PMID: 32791115 DOI: 10.1016/j.chom.2020.07.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
10 Anderson MS, Valbuena VSM, Brown CS, Waits SA, Sonnenday CJ, Englesbe M, Mellinger JL. Association of COVID-19 With New Waiting List Registrations and Liver Transplantation for Alcoholic Hepatitis in the United States. JAMA Netw Open 2021;4:e2131132. [PMID: 34698851 DOI: 10.1001/jamanetworkopen.2021.31132] [Reference Citation Analysis]
11 Dimova RB, Rude E, Talal AH. Age- and risk factor-based serologic screening for Hepatitis C virus among an Urban, high-risk population. J Viral Hepat 2020;27:1369-87. [PMID: 32615009 DOI: 10.1111/jvh.13359] [Reference Citation Analysis]
12 Aslam S, Buggs J, Melo S, Ermekbaeva A, Rogers E, Shaw R, Kumar A, Kemmer N. The Association Between Alcoholic Liver Disease and Alcohol Tax. The American Surgeon 2021;87:92-6. [DOI: 10.1177/0003134820945223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Buchanan R, Sinclair JMA. Alcohol use disorder and the liver. Addiction 2021;116:1270-8. [PMID: 32710592 DOI: 10.1111/add.15204] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 German MN, Eccleston JL, Tamez DA, Remington PL, Lucey MR. Internet Published Policies Regarding Liver Transplant Eligibility and Substance Use in United States Transplant Centers. Hepatol Commun 2020;4:1717-24. [PMID: 33163840 DOI: 10.1002/hep4.1591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ayyala-Somayajula D, Han H, Terrault NA. Selective use of liver transplantation for severe alcohol-associated hepatitis. Expert Rev Gastroenterol Hepatol 2020;14:175-84. [PMID: 32077333 DOI: 10.1080/17474124.2020.1733414] [Reference Citation Analysis]
16 Pose E, Torrents A, Reverter E, Perez-Campuzano V, Campos-Varela I, Avitabile E, Gratacós-Ginès J, Castellote J, Castells L, Colmenero J, Tort J, Ginès P, Crespo G. A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement. J Hepatol 2021;75:275-83. [PMID: 33746085 DOI: 10.1016/j.jhep.2021.02.033] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Delman AM, Ammann AM, Shah SA. The current status of virus-positive liver transplantation. Curr Opin Organ Transplant 2021;26:160-7. [PMID: 33595981 DOI: 10.1097/MOT.0000000000000850] [Reference Citation Analysis]
18 Winder GS, Fernandez AC, Klevering K, Mellinger JL. Confronting the Crisis of Comorbid Alcohol Use Disorder and Alcohol-Related Liver Disease With a Novel Multidisciplinary Clinic. Psychosomatics 2020;61:238-53. [PMID: 32033835 DOI: 10.1016/j.psym.2019.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Lee BP, Vittinghoff E, Pletcher MJ, Dodge JL, Terrault NA. Medicaid Policy and Liver Transplant for Alcohol-Associated Liver Disease. Hepatology 2020;72:130-9. [PMID: 31705545 DOI: 10.1002/hep.31027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
20 Moon AM, Yang JY, Barritt AS, Bataller R, Peery AF. Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century. Am J Gastroenterol 2020;115:79-87. [DOI: 10.14309/ajg.0000000000000442] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
21 Satapathy SK, Thornburgh C, Heda R, Jiang Y, Kedia SK, Nair SP, Eason JD, Maluf D. Predicting harmful alcohol relapse after liver transplant: The HALT score. Clin Transplant 2020;34:e14003. [PMID: 32506677 DOI: 10.1111/ctr.14003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Wan S, Nie Y, Zhu X. Development of a prognostic scoring model for predicting the survival of elderly patients with hepatocellular carcinoma. PeerJ 2020;8:e8497. [PMID: 32117619 DOI: 10.7717/peerj.8497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Roth EM, Lee EJ, Cameron AM, Shen NT, Brown RS Jr, DiMartini AF, Shenoy A. A Young Patient with Brief Alcohol Use and Rapidly Progressive Alcohol-Related Hepatitis: Considerations in Transplant Eligibility. Harv Rev Psychiatry 2020;28:133-42. [PMID: 32134837 DOI: 10.1097/HRP.0000000000000249] [Reference Citation Analysis]
24 Sharma SP, Suk KT, Kim DJ. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World J Gastroenterol 2021; 27(37): 6161-6179 [PMID: 34712025 DOI: 10.3748/wjg.v27.i37.6161] [Reference Citation Analysis]
25 Cotter TG, Sandıkçı B, Paul S, Gampa A, Wang J, Te H, Pillai A, Reddy KG, Sabato D, Little EC, Sundaram V, Fung J, Lucey MR, Charlton M. Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency. Am J Transplant 2021;21:1039-55. [DOI: 10.1111/ajt.16143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
26 Younossi ZM, Stepanova M, Ong J, Trimble G, AlQahtani S, Younossi I, Ahmed A, Racila A, Henry L. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States. Clin Gastroenterol Hepatol. 2021;19:580-589.e5. [PMID: 32531342 DOI: 10.1016/j.cgh.2020.05.064] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
27 Chu H, Duan Y, Lang S, Jiang L, Wang Y, Llorente C, Liu J, Mogavero S, Bosques-Padilla F, Abraldes JG, Vargas V, Tu XM, Yang L, Hou X, Hube B, Stärkel P, Schnabl B. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease. J Hepatol 2020;72:391-400. [PMID: 31606552 DOI: 10.1016/j.jhep.2019.09.029] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 9.3] [Reference Citation Analysis]
28 Mellinger JL, Stine JG. Early Liver Transplantation for Severe Alcoholic Hepatitis. Dig Dis Sci 2020;65:1608-14. [PMID: 32107678 DOI: 10.1007/s10620-020-06159-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Masson S, Aldersley H, Leithead JA, Day E, Langford A, Healy P, O'Grady J, Thorburn D, Parker C, Shepherd L, Arndtz K, Webb K, Holt A. Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referral. Lancet Gastroenterol Hepatol 2021;6:947-55. [PMID: 34626562 DOI: 10.1016/S2468-1253(21)00195-3] [Reference Citation Analysis]
30 Lee BP, Dodge JL, Terrault NA. Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease. Am J Gastroenterol 2021;116:551-9. [PMID: 33136566 DOI: 10.14309/ajg.0000000000001007] [Reference Citation Analysis]
31 Arab JP, Izzy M, Leggio L, Bataller R, Shah VH. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34725498 DOI: 10.1038/s41575-021-00527-0] [Reference Citation Analysis]
32 Crismale JF, Ahmad J. Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation. World J Gastroenterol 2019; 25(47): 6799-6812 [PMID: 31885421 DOI: 10.3748/wjg.v25.i47.6799] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
33 Xu JJ, Li HD, Wu MF, Zhu L, Du XS, Li JJ, Li Z, Meng XM, Huang C, Li J. 3-B-RUT, a derivative of RUT, protected against alcohol-induced liver injury by attenuating inflammation and oxidative stress. Int Immunopharmacol 2021;95:107471. [PMID: 33756231 DOI: 10.1016/j.intimp.2021.107471] [Reference Citation Analysis]
34 Duan Y, Chu H, Brandl K, Jiang L, Zeng S, Meshgin N, Papachristoforou E, Argemi J, Mendes BG, Wang Y, Su H, Sun W, Llorente C, Hendrikx T, Liu X, Hosseini M, Kisseleva T, Brenner DA, Bataller R, Ramachandran P, Karin M, Fu W, Schnabl B. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. Nat Commun 2021;12:7172. [PMID: 34887405 DOI: 10.1038/s41467-021-27385-3] [Reference Citation Analysis]
35 Ivanics T, Abreu P, De Martin E, Sapisochin G. Changing Trends in Liver Transplantation: Challenges and Solutions. Transplantation 2021;105:743-56. [PMID: 32910093 DOI: 10.1097/TP.0000000000003454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
36 Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, White RC, Clarke TH, Nguyen K, Torralba M, Shao Y, Liu J, Hernandez-Morales A, Lessor L, Rahman IR, Miyamoto Y, Ly M, Gao B, Sun W, Kiesel R, Hutmacher F, Lee S, Ventura-Cots M, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS Jr, Vargas V, Altamirano J, Caballería J, Shawcross DL, Ho SB, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Bataller R, Tu XM, Eckmann L, van der Donk WA, Young R, Lawley TD, Stärkel P, Pride D, Fouts DE, Schnabl B. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature 2019;575:505-11. [PMID: 31723265 DOI: 10.1038/s41586-019-1742-x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 157] [Article Influence: 55.0] [Reference Citation Analysis]
37 Xiang X, Hwang S, Feng D, Shah VH, Gao B. Interleukin-22 in alcoholic hepatitis and beyond. Hepatol Int 2020;14:667-76. [PMID: 32892258 DOI: 10.1007/s12072-020-10082-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
38 Lee BP, Dodge JL, Terrault NA. Changes and mediators of survival disparity among Black liver transplant recipients in the United States. Am J Transplant 2021. [PMID: 34374495 DOI: 10.1111/ajt.16767] [Reference Citation Analysis]
39 Deutsch-Link S, Weinrieb RM, Jones LS, Solga SF, Weinberg EM, Serper M. Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation. Dig Dis Sci 2020;65:2089-103. [PMID: 31707529 DOI: 10.1007/s10620-019-05937-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
40 Hause J, Rice JP. Transplants for Acute Alcoholic Hepatitis: Controversies and Early Successes. Clin Liver Dis 2021;25:229-52. [PMID: 33978581 DOI: 10.1016/j.cld.2020.08.010] [Reference Citation Analysis]
41 Hochheimer M, Moreland ML, Tuten M, LaMattina J, Connelly M, Sacco P. Insights Into the Experience of Liver Transplant Recipients With Alcoholic Liver Disease: A Descriptive Qualitative Study. Transplant Direct 2019;5:e506. [PMID: 32095501 DOI: 10.1097/TXD.0000000000000951] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Han S, Yang Z, Zhang T, Ma J, Chandler K, Liangpunsakul S. Epidemiology of Alcohol-Associated Liver Disease. Clin Liver Dis 2021;25:483-92. [PMID: 34229835 DOI: 10.1016/j.cld.2021.03.009] [Reference Citation Analysis]
43 Lee BP, Im GY, Rice JP, Lazar A, Weinberg E, Han H, Maddur H, Ghobrial RM, Therapondos G, Hsu C, Fix OK, Eswaran S, Shetty K, Chhatwal J, Dalgic OO, Jakhete N, Mobley C, Victor DW, Mehta N, Dinges L, Rinella M, Schiano TD, Lucey MR, Terrault N. Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31558-5. [PMID: 33279780 DOI: 10.1016/j.cgh.2020.11.024] [Reference Citation Analysis]
44 Tapper EB, Parikh ND, Liangpunsakul S. Attacking Alcohol-Related Liver Disease by Taxing Alcohol Sales. Alcohol Clin Exp Res 2021;45:51-3. [PMID: 33164216 DOI: 10.1111/acer.14500] [Reference Citation Analysis]
45 Gao W, Zhu Y, Ye J, Chu H. Gut non-bacterial microbiota contributing to alcohol-associated liver disease. Gut Microbes 2021;13:1984122. [PMID: 34711112 DOI: 10.1080/19490976.2021.1984122] [Reference Citation Analysis]
46 Mellinger J, Winder GS, Fernandez AC. Measuring the Alcohol in Alcohol-Associated Liver Disease: Choices and Challenges for Clinical Research. Hepatology 2021;73:1207-12. [PMID: 32886409 DOI: 10.1002/hep.31539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Shen NT, Bray J, Wahid NA, Raver M, Hutchison N, Brown RS Jr, Schackman BR. Evaluation of Alcohol Taxes as a Public Health Opportunity to Reduce Liver Transplant Listings for Alcohol-Related Liver Disease. Alcohol Clin Exp Res 2020;44:2307-15. [PMID: 32944958 DOI: 10.1111/acer.14454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Doshi SD, Stotts MJ, Hubbard RA, Goldberg DS. The Changing Burden of Alcoholic Hepatitis: Rising Incidence and Associations with Age, Gender, Race, and Geography. Dig Dis Sci 2021;66:1707-14. [PMID: 32436122 DOI: 10.1007/s10620-020-06346-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Giard J, Dodge JL, Terrault NA. Superior Wait‐List Outcomes in Patients with Alcohol‐Associated Liver Disease Compared With Other Indications for Liver Transplantation. Liver Transpl 2019;25:1310-20. [DOI: 10.1002/lt.25485] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
50 Niazi SK, Spaulding A, Vargas E, Schneekloth T, Crook J, Rummans T, Taner CB. Mental health and chemical dependency services at US transplant centers. Am J Transplant 2020;20:1152-61. [PMID: 31612625 DOI: 10.1111/ajt.15659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Wang S, Toy M, Hang Pham TT, So S. Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019. PLoS One 2020;15:e0239393. [PMID: 32946502 DOI: 10.1371/journal.pone.0239393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
52 Asrani SK, Trotter J, Lake J, Ahmed A, Bonagura A, Cameron A, DiMartini A, Gonzalez S, Im G, Martin P, Mathurin P, Mellinger J, Rice JP, Shah VH, Terrault N, Wall A, Winder S, Klintmalm G. Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis. Liver Transpl 2020;26:127-40. [PMID: 31743578 DOI: 10.1002/lt.25681] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 28.0] [Reference Citation Analysis]
53 Moon AM, Curtis B, Mandrekar P, Singal AK, Verna EC, Fix OK. Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation. Hepatol Commun 2021. [PMID: 34222743 DOI: 10.1002/hep4.1747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Da BL, Im GY, Schiano TD. Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease. Hepatology. 2020;72:1102-1108. [PMID: 32369624 DOI: 10.1002/hep.31307] [Cited by in Crossref: 57] [Cited by in F6Publishing: 70] [Article Influence: 28.5] [Reference Citation Analysis]
55 Liu SY, Tsai IT, Hsu YC. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. Int J Mol Sci 2021;22:5170. [PMID: 34068269 DOI: 10.3390/ijms22105170] [Reference Citation Analysis]
56 Wan S, Lei Y, Li M, Wu B. A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes. Hepatol Int 2021. [PMID: 34449009 DOI: 10.1007/s12072-021-10248-w] [Reference Citation Analysis]
57 German MN, Musto J, Lucey MR. Novel treatments for alcoholic hepatitis. Curr Opin Gastroenterol 2021;37:179-86. [PMID: 33769374 DOI: 10.1097/MOG.0000000000000725] [Reference Citation Analysis]
58 Campos-Varela I, Dodge JL, Terrault NA, Brandman D, Price JC. Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus. Am J Transplant 2021;21:3148-56. [PMID: 33749113 DOI: 10.1111/ajt.16569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Çolakoğlu M, Xue J, Trajkovski M. Bacteriophage Prevents Alcoholic Liver Disease. Cell 2020;180:218-20. [PMID: 31978341 DOI: 10.1016/j.cell.2019.12.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]